Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

16.65USD
15 Dec 2017
Change (% chg)

$0.34 (+2.08%)
Prev Close
$16.31
Open
$16.30
Day's High
$17.32
Day's Low
$16.00
Volume
474,038
Avg. Vol
60,594
52-wk High
$26.74
52-wk Low
$13.54

Latest Key Developments (Source: Significant Developments)

Kala Pharmaceuticals reports Q3 loss per share $0.56
Tuesday, 7 Nov 2017 07:30am EST 

Nov 7 (Reuters) - Kala Pharmaceuticals Inc :Kala Pharmaceuticals reports third quarter 2017 financial results and provides business update.Q3 loss per share $0.56.Kala Pharmaceuticals - ‍Top-line results from phase 3 clinical program for KPI-121 0.25% in patients with dry eye disease are expected by end of 2017​.Kala Pharmaceuticals Inc - ‍Expects that its existing cash on hand will enable it to fund operations through Q2 of 2019​.  Full Article

Kala Pharmaceuticals submits new drug application for Inveltystm
Wednesday, 25 Oct 2017 08:00am EDT 

Oct 25 (Reuters) - Kala Pharmaceuticals Inc :Kala pharmaceuticals submits new drug application to U.S. Food and Drug Administration for Inveltystm (KPI-121 1 pct).  Full Article

Wellington Management Group reports 11.84 pct passive stake in Kala Pharmaceuticals - SEC filing‍​
Thursday, 10 Aug 2017 11:21am EDT 

Aug 10 (Reuters) - Wellington Management Group LLP::Wellington Management Group LLP reports 11.84 percent passive stake in Kala Pharmaceuticals Inc as of July 31, 2017 - SEC filing‍​.  Full Article

Kala Pharmaceuticals shares open at $16.70 in debut vs IPO price of $15/shr
Thursday, 20 Jul 2017 09:58am EDT 

July 20 (Reuters) - :Kala Pharmaceuticals Inc shares open at $16.70 in debut on the Nasdaq versus IPO price of $15.00 per share.  Full Article

Kala Pharma announces pricing of initial public offering
Thursday, 20 Jul 2017 08:00am EDT 

July 20 (Reuters) - Kala Pharmaceuticals Inc ::Kala Pharmaceuticals announces pricing of initial public offering.Says initial public offering of 6.00 million common shares priced at $15.00per share.Kala Pharmaceuticals Inc - priced its initial public offering for aggregate gross proceeds of approximately $90.0 million.  Full Article

Kala Pharma sees IPO of 6 mln shares priced between $14-$16/shr
Monday, 10 Jul 2017 07:02am EDT 

July 10 (Reuters) - Kala Pharmaceuticals Inc ::Kala Pharmaceuticals sees IPO of 6 million shares of co's common stock priced between $14.00 and $16.00 per share.  Full Article

BRIEF-Kala Pharmaceuticals reports Q3 loss per share $0.56

* Kala Pharmaceuticals reports third quarter 2017 financial results and provides business update